Selected research
Industry Research
Parathyroid Hormone Analog Industry Research Report 2026
Market perspective
The global Parathyroid Hormone Analog market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Parathyroid Hormone Analog is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Parathyroid Hormone Analog is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Parathyroid Hormone Analog is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Parathyroid Hormone Analog include Abbott Laboratories, ALZA Corporation, Cell Genesys Inc, Natpara, OSI Pharmaceuticals, Paladin Labs Inc, GlaxoSmithKline Plc, Pfizer and Eli Lilly, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Parathyroid Hormone Analog market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Parathyroid Hormone Analog Market by Company
Abbott Laboratories
ALZA Corporation
Cell Genesys Inc
Natpara
OSI Pharmaceuticals
Paladin Labs Inc
GlaxoSmithKline Plc
Pfizer
Eli Lilly
Merck
Sanofi SA
Parathyroid Hormone Analog Segment by Type
Abaloparatide
Human Parathyroid Hormone Recombinant
Teriparatide
Parathyroid Hormone Analog Segment by Application
Hospitals
Clinics
Other
Parathyroid Hormone Analog Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parathyroid Hormone Analog market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parathyroid Hormone Analog and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parathyroid Hormone Analog.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Parathyroid Hormone Analog manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Parathyroid Hormone Analog by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Parathyroid Hormone Analog in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Abaloparatide
- Human Parathyroid Hormone Recombinant
- Teriparatide
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Abbott Laboratories
- ALZA Corporation
- Cell Genesys Inc
- Natpara
- OSI Pharmaceuticals
- Paladin Labs Inc
- GlaxoSmithKline Plc
- Pfizer
- Eli Lilly
- Merck
- Sanofi SA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Parathyroid Hormone Analog Market Size (2021-2032)
- 2.2.2 Global Parathyroid Hormone Analog Sales (2021-2032)
- 2.2.3 Global Parathyroid Hormone Analog Market Average Price (2021-2032)
- 2.3 Parathyroid Hormone Analog by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Abaloparatide
- 2.3.3 Human Parathyroid Hormone Recombinant
- 2.3.4 Teriparatide
- 2.4 Parathyroid Hormone Analog by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Parathyroid Hormone Analog Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Parathyroid Hormone Analog Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Parathyroid Hormone Analog Revenue of Manufacturers (2021-2026)
- 3.4 Global Parathyroid Hormone Analog Average Price by Manufacturers (2021-2026)
- 3.5 Global Parathyroid Hormone Analog Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Parathyroid Hormone Analog, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Parathyroid Hormone Analog, Product Type & Application
- 3.8 Global Manufacturers of Parathyroid Hormone Analog, Established Date
- 3.9 Global Parathyroid Hormone Analog Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott Laboratories
- 4.1.1 Abbott Laboratories Company Information
- 4.1.2 Abbott Laboratories Business Overview
- 4.1.3 Abbott Laboratories Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Laboratories Parathyroid Hormone Analog Product Portfolio
- 4.1.5 Abbott Laboratories Recent Developments
- 4.2 ALZA Corporation
- 4.2.1 ALZA Corporation Company Information
- 4.2.2 ALZA Corporation Business Overview
- 4.2.3 ALZA Corporation Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 ALZA Corporation Parathyroid Hormone Analog Product Portfolio
- 4.2.5 ALZA Corporation Recent Developments
- 4.3 Cell Genesys Inc
- 4.3.1 Cell Genesys Inc Company Information
- 4.3.2 Cell Genesys Inc Business Overview
- 4.3.3 Cell Genesys Inc Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cell Genesys Inc Parathyroid Hormone Analog Product Portfolio
- 4.3.5 Cell Genesys Inc Recent Developments
- 4.4 Natpara
- 4.4.1 Natpara Company Information
- 4.4.2 Natpara Business Overview
- 4.4.3 Natpara Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Natpara Parathyroid Hormone Analog Product Portfolio
- 4.4.5 Natpara Recent Developments
- 4.5 OSI Pharmaceuticals
- 4.5.1 OSI Pharmaceuticals Company Information
- 4.5.2 OSI Pharmaceuticals Business Overview
- 4.5.3 OSI Pharmaceuticals Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 OSI Pharmaceuticals Parathyroid Hormone Analog Product Portfolio
- 4.5.5 OSI Pharmaceuticals Recent Developments
- 4.6 Paladin Labs Inc
- 4.6.1 Paladin Labs Inc Company Information
- 4.6.2 Paladin Labs Inc Business Overview
- 4.6.3 Paladin Labs Inc Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Paladin Labs Inc Parathyroid Hormone Analog Product Portfolio
- 4.6.5 Paladin Labs Inc Recent Developments
- 4.7 GlaxoSmithKline Plc
- 4.7.1 GlaxoSmithKline Plc Company Information
- 4.7.2 GlaxoSmithKline Plc Business Overview
- 4.7.3 GlaxoSmithKline Plc Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GlaxoSmithKline Plc Parathyroid Hormone Analog Product Portfolio
- 4.7.5 GlaxoSmithKline Plc Recent Developments
- 4.8 Pfizer
- 4.8.1 Pfizer Company Information
- 4.8.2 Pfizer Business Overview
- 4.8.3 Pfizer Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer Parathyroid Hormone Analog Product Portfolio
- 4.8.5 Pfizer Recent Developments
- 4.9 Eli Lilly
- 4.9.1 Eli Lilly Company Information
- 4.9.2 Eli Lilly Business Overview
- 4.9.3 Eli Lilly Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Eli Lilly Parathyroid Hormone Analog Product Portfolio
- 4.9.5 Eli Lilly Recent Developments
- 4.10 Merck
- 4.10.1 Merck Company Information
- 4.10.2 Merck Business Overview
- 4.10.3 Merck Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Merck Parathyroid Hormone Analog Product Portfolio
- 4.10.5 Merck Recent Developments
- 4.11 Sanofi SA
- 4.11.1 Sanofi SA Company Information
- 4.11.2 Sanofi SA Business Overview
- 4.11.3 Sanofi SA Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sanofi SA Parathyroid Hormone Analog Product Portfolio
- 4.11.5 Sanofi SA Recent Developments
5 Global Parathyroid Hormone Analog Market Scenario by Region
- 5.1 Global Parathyroid Hormone Analog Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Parathyroid Hormone Analog Sales by Region: 2021-2032
- 5.2.1 Global Parathyroid Hormone Analog Sales by Region: 2021-2026
- 5.2.2 Global Parathyroid Hormone Analog Sales by Region: 2027-2032
- 5.3 Global Parathyroid Hormone Analog Revenue by Region: 2021-2032
- 5.3.1 Global Parathyroid Hormone Analog Revenue by Region: 2021-2026
- 5.3.2 Global Parathyroid Hormone Analog Revenue by Region: 2027-2032
- 5.4 North America Parathyroid Hormone Analog Market Facts & Figures by Country
- 5.4.1 North America Parathyroid Hormone Analog Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Parathyroid Hormone Analog Sales by Country (2021-2032)
- 5.4.3 North America Parathyroid Hormone Analog Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Parathyroid Hormone Analog Market Facts & Figures by Country
- 5.5.1 Europe Parathyroid Hormone Analog Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Parathyroid Hormone Analog Sales by Country (2021-2032)
- 5.5.3 Europe Parathyroid Hormone Analog Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Parathyroid Hormone Analog Market Facts & Figures by Country
- 5.6.1 Asia Pacific Parathyroid Hormone Analog Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Parathyroid Hormone Analog Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Parathyroid Hormone Analog Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Parathyroid Hormone Analog Market Facts & Figures by Country
- 5.7.1 South America Parathyroid Hormone Analog Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Parathyroid Hormone Analog Sales by Country (2021-2032)
- 5.7.3 South America Parathyroid Hormone Analog Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Parathyroid Hormone Analog Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Parathyroid Hormone Analog Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Parathyroid Hormone Analog Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Parathyroid Hormone Analog Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Parathyroid Hormone Analog Sales by Type (2021-2032)
- 6.1.1 Global Parathyroid Hormone Analog Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Parathyroid Hormone Analog Sales Market Share by Type (2021-2032)
- 6.2 Global Parathyroid Hormone Analog Revenue by Type (2021-2032)
- 6.2.1 Global Parathyroid Hormone Analog Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Parathyroid Hormone Analog Revenue Market Share by Type (2021-2032)
- 6.3 Global Parathyroid Hormone Analog Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Parathyroid Hormone Analog Sales by Application (2021-2032)
- 7.1.1 Global Parathyroid Hormone Analog Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Parathyroid Hormone Analog Sales Market Share by Application (2021-2032)
- 7.2 Global Parathyroid Hormone Analog Revenue by Application (2021-2032)
- 7.2.1 Global Parathyroid Hormone Analog Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Parathyroid Hormone Analog Revenue Market Share by Application (2021-2032)
- 7.3 Global Parathyroid Hormone Analog Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Parathyroid Hormone Analog Value Chain Analysis
- 8.1.1 Parathyroid Hormone Analog Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Parathyroid Hormone Analog Production Mode & Process
- 8.2 Parathyroid Hormone Analog Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Parathyroid Hormone Analog Distributors
- 8.2.3 Parathyroid Hormone Analog Customers
9 Global Parathyroid Hormone Analog Analyzing Market Dynamics
- 9.1 Parathyroid Hormone Analog Industry Trends
- 9.2 Parathyroid Hormone Analog Industry Drivers
- 9.3 Parathyroid Hormone Analog Industry Opportunities and Challenges
- 9.4 Parathyroid Hormone Analog Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst